172 related articles for article (PubMed ID: 12477573)
1. Effects of short-term alendronate treatment on the three-dimensional microstructural, physical, and mechanical properties of dog trabecular bone.
Hu JH; Ding M; Søballe K; Bechtold JE; Danielsen CC; Day JS; Hvid I
Bone; 2002 Nov; 31(5):591-7. PubMed ID: 12477573
[TBL] [Abstract][Full Text] [Related]
2. Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates.
Ding M; Day JS; Burr DB; Mashiba T; Hirano T; Weinans H; Sumner DR; Hvid I
Calcif Tissue Int; 2003 Jun; 72(6):737-44. PubMed ID: 14563003
[TBL] [Abstract][Full Text] [Related]
3. Effects of alendronate on structural properties of trabecular bone in dogs.
Jianhua H; Liang Z; Lilian Z; Gongyi H
Chin Med Sci J; 2002 Dec; 17(4):210-4. PubMed ID: 12901507
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate treatment changes regional distribution of trabecular microstructure in human lumbar vertebrae.
Vom Scheidt A; Hemmatian H; Püschel K; Krause M; Amling M; Busse B
Bone; 2019 Oct; 127():482-487. PubMed ID: 31280018
[TBL] [Abstract][Full Text] [Related]
5. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.
Allen MR; Burr DB
J Bone Miner Res; 2007 Nov; 22(11):1759-65. PubMed ID: 17663638
[TBL] [Abstract][Full Text] [Related]
6. Trabecular bone microarchitecture after alendronate treatment of osteoporotic women.
Recker R; Masarachia P; Santora A; Howard T; Chavassieux P; Arlot M; Rodan G; Wehren L; Kimmel D
Curr Med Res Opin; 2005 Feb; 21(2):185-94. PubMed ID: 15801989
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.
Day JS; Ding M; Bednarz P; van der Linden JC; Mashiba T; Hirano T; Johnston CC; Burr DB; Hvid I; Sumner DR; Weinans H
J Orthop Res; 2004 May; 22(3):465-71. PubMed ID: 15099622
[TBL] [Abstract][Full Text] [Related]
8. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
Allen MR; McNerny E; Aref M; Organ JM; Newman CL; McGowan B; Jang T; Burr DB; Brown DM; Hammond M; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Hutchins GD; Wallace JM
PLoS One; 2017; 12(8):e0181750. PubMed ID: 28793321
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional microarchitecture of adolescent cancellous bone.
Ding M; Danielsen CC; Hvid I; Overgaard S
Bone; 2012 Nov; 51(5):953-60. PubMed ID: 22884723
[TBL] [Abstract][Full Text] [Related]
10. Three years of alendronate treatment does not continue to decrease microstructural stresses and strains associated with trabecular microdamage initiation beyond those at 1 year.
Green JO; Diab T; Allen MR; Vidakovic B; Burr DB; Guldberg RE
Osteoporos Int; 2012 Sep; 23(9):2313-20. PubMed ID: 22237815
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling.
Borah B; Dufresne TE; Cockman MD; Gross GJ; Sod EW; Myers WR; Combs KS; Higgins RE; Pierce SA; Stevens ML
J Bone Miner Res; 2000 Sep; 15(9):1786-97. PubMed ID: 10976998
[TBL] [Abstract][Full Text] [Related]
12. Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra.
Diab T; Allen MR; Burr DB
Osteoporos Int; 2009 Apr; 20(4):647-52. PubMed ID: 18716822
[TBL] [Abstract][Full Text] [Related]
13. High-resolution magnetic resonance imaging: three-dimensional trabecular bone architecture and biomechanical properties.
Majumdar S; Kothari M; Augat P; Newitt DC; Link TM; Lin JC; Lang T; Lu Y; Genant HK
Bone; 1998 May; 22(5):445-54. PubMed ID: 9600777
[TBL] [Abstract][Full Text] [Related]
14. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
Allen MR; Iwata K; Phipps R; Burr DB
Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
[TBL] [Abstract][Full Text] [Related]
15. Age variations in the properties of human tibial trabecular bone and cartilage.
Ding M
Acta Orthop Scand Suppl; 2000 Jun; 292():1-45. PubMed ID: 10951715
[TBL] [Abstract][Full Text] [Related]
16. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
Luo Y; Zhang L; Wang WY; Hu QF; Song HP; Su YL; Zhang YZ
Bone; 2013 Aug; 55(2):439-48. PubMed ID: 23500174
[TBL] [Abstract][Full Text] [Related]
17. Mechanical properties of ewe vertebral cancellous bone compared with histomorphometry and high-resolution computed tomography parameters.
Mitton D; Cendre E; Roux JP; Arlot ME; Peix G; Rumelhart C; Babot D; Meunier PJ
Bone; 1998 Jun; 22(6):651-8. PubMed ID: 9626404
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term alendronate treatment on bone mineralisation, resorption parameters and biomechanics of single human vertebral trabeculae.
Krause M; Soltau M; Zimmermann EA; Hahn M; Kornet J; Hapfelmeier A; Breer S; Morlock M; Wulff B; Püschel K; Glueer CC; Amling M; Busse B
Eur Cell Mater; 2014 Sep; 28():152-63; discussion 163-5. PubMed ID: 25241965
[TBL] [Abstract][Full Text] [Related]
19. Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.
Rudge S; Hailwood S; Horne A; Lucas J; Wu F; Cundy T
Rheumatology (Oxford); 2005 Jun; 44(6):813-8. PubMed ID: 15695300
[TBL] [Abstract][Full Text] [Related]
20. Human cancellous bone from T12-L1 vertebrae has unique microstructural and trabecular shear stress properties.
Yeni YN; Kim DG; Divine GW; Johnson EM; Cody DD
Bone; 2009 Jan; 44(1):130-6. PubMed ID: 18848654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
